| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |